ALX ONCOLOGY Trademark

Trademark Overview

On Tuesday, March 6, 2018, a trademark application was filed for ALX ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the ALX ONCOLOGY trademark a serial number of 87822154. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, March 4, 2026. This trademark is owned by ALX Oncology, Inc.. The ALX ONCOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for the treatment of cancer
alx oncology

General Information

Serial Number87822154
Word MarkALX ONCOLOGY
Filing DateTuesday, March 6, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, March 4, 2026
Registration Number5938756
Registration DateTuesday, December 17, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements

NOT AVAILABLE"ONCOLOGY"
Goods and Servicespharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 12, 2018
Primary Code005
First Use Anywhere DateWednesday, May 8, 2019
First Use In Commerce DateWednesday, May 8, 2019

Trademark Owner History

Party NameALX Oncology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080
US
Party NameALX Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94010
US
Party NameALX Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94010
US

Trademark Events

Event DateEvent Description
Friday, March 9, 2018NEW APPLICATION ENTERED
Monday, March 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 18, 2018ASSIGNED TO EXAMINER
Tuesday, June 19, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 19, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, June 19, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 19, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, June 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 6, 2018ASSIGNED TO LIE
Friday, July 6, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 15, 2019SOU TEAS EXTENSION RECEIVED
Friday, March 15, 2019SOU EXTENSION 1 FILED
Friday, March 15, 2019SOU EXTENSION 1 GRANTED
Tuesday, March 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, October 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 7, 2019USE AMENDMENT FILED
Thursday, October 24, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, November 8, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 9, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 17, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 1, 2025TEAS SECTION 8 & 15 RECEIVED
Wednesday, March 4, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 4, 2026REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, March 4, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

oncology cancer treatment pharmaceuticals